But if you enroll you might be on the drug for the length of the trial. And probably after as well. That was the case for brensocatib. Even if you were on the placebo, you were giving me the option after completing the trial to go on the drug. I know someone in New Zealand, who was on the drug during the trial and then continued. For her, it was life-changing.